Abnormal Acidification of Melanoma Cells Induces Tyrosinase Retention in the Early Secretory Pathway*

In tyrosinase-positive amelanotic melanoma cells, inactive tyrosinase accumulates in the endoplasmic reticulum. Based on studies described here, we propose that aberrant vacuolar proton ATPase (V-ATPase)-mediated proton transport in melanoma cells disrupts tyrosinase trafficking through the secretory pathway. Amelanotic but not melanotic melanoma cells or normal melanocytes display elevated proton export as observed by the acidification of the extracellular medium and their ability to maintain neutral intracellular pH. Tyrosinase activity and transit through the Golgi were restored by either maintaining the melanoma cells in alkaline medium (pH 7.4–7.7) or by restricting glucose uptake. The translocation of tyrosinase out of the endoplasmic reticulum and the induction of cell pigmentation in the presence of the ionophore monensin or the specific V-ATPase inhibitors concanamycin A and bafilomycin A1 supported a role for V-ATPases in this process. Because it was previously shown that V-ATPase activity is increased in solid tumors in response to an acidified environment, the appearance of hypopigmented cells in tyrosinase-positive melanoma tumors may indicate the onset of enhanced glycolysis and extracellular acidification, conditions known to favor metastatic spread and resistance to weak base chemotherapeutic drugs.

[1]  K. Wakamatsu,et al.  Melanosomal pH controls rate of melanogenesis, eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and melanoma cells. , 2001, Experimental cell research.

[2]  R. Burd,et al.  Absence of Crabtree effect in human melanoma cells adapted to growth at low pH: reversal by respiratory inhibitors. , 2001, Cancer research.

[3]  M. Hoogduijn,et al.  Melanosomal pH, pink locus protein and their roles in melanogenesis. , 2001, The Journal of investigative dermatology.

[4]  Takashi Saito,et al.  The KDEL receptor mediates a retrieval mechanism that contributes to quality control at the endoplasmic reticulum , 2001, The EMBO journal.

[5]  R. Spritz,et al.  The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation. , 2001, The Biochemical journal.

[6]  R. Halaban,et al.  Proper Folding and Endoplasmic Reticulum to Golgi Transport of Tyrosinase Are Induced by Its Substrates, DOPA and Tyrosine* , 2001, The Journal of Biological Chemistry.

[7]  M. Brilliant The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH. , 2001, Pigment cell research.

[8]  T. Eisenhaure,et al.  Translation Rate of Human Tyrosinase Determines ItsN-Linked Glycosylation Level* , 2001, The Journal of Biological Chemistry.

[9]  G. Raposo,et al.  Distinct Protein Sorting and Localization to Premelanosomes, Melanosomes, and Lysosomes in Pigmented Melanocytic Cells✪ , 2001, The Journal of cell biology.

[10]  B. Fuller,et al.  Regulation of the catalytic activity of preexisting tyrosinase in black and Caucasian human melanocyte cell cultures. , 2001, Experimental cell research.

[11]  M. Brilliant,et al.  Aberrant pH of melanosomes in pink-eyed dilution (p) mutant melanocytes. , 2000, The Journal of investigative dermatology.

[12]  P. Briand,et al.  Intracellular pH regulation in a nonmalignant and a derived malignant human breast cell line , 2000, Journal of cellular physiology.

[13]  R. Halaban,et al.  Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Marks,et al.  A Common Temperature-sensitive Allelic Form of Human Tyrosinase Is Retained in the Endoplasmic Reticulum at the Nonpermissive Temperature* , 2000, The Journal of Biological Chemistry.

[15]  R. Halaban,et al.  Deregulated E2f Transcriptional Activity in Autonomously Growing Melanoma Cells , 2000, The Journal of experimental medicine.

[16]  R. Tsien,et al.  Organelle pH studies using targeted avidin and fluorescein-biotin. , 2000, Chemistry & biology.

[17]  J R Griffiths,et al.  Causes and consequences of tumour acidity and implications for treatment. , 2000, Molecular medicine today.

[18]  R. Tsien,et al.  Studying organelle physiology with fusion protein-targeted avidin and fluorescent biotin conjugates. , 2000, Methods in enzymology.

[19]  A Helenius,et al.  Setting the standards: quality control in the secretory pathway. , 1999, Science.

[20]  Riley Pa The great DOPA mystery: the source and significance of DOPA in phase I melanogenesis. , 1999 .

[21]  M Forgac,et al.  Structure and Properties of the Vacuolar (H+)-ATPases* , 1999, The Journal of Biological Chemistry.

[22]  R. Gillies,et al.  pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines. , 1999, Biochemical pharmacology.

[23]  N. Nelson,et al.  Vacuolar and plasma membrane proton-adenosinetriphosphatases. , 1999, Physiological reviews.

[24]  M. Brilliant,et al.  The pink-eyed dilution locus controls the biogenesis of melanosomes and levels of melanosomal proteins in the eye. , 1999, Experimental eye research.

[25]  Simon,et al.  Role of organelle pH in tumor cell biology and drug resistance. , 1999, Drug discovery today.

[26]  K. Väänänen,et al.  Retrograde transport from the pre-Golgi intermediate compartment and the Golgi complex is affected by the vacuolar H+-ATPase inhibitor bafilomycin A1. , 1998, Molecular biology of the cell.

[27]  D. Bennett,et al.  Normal tyrosine transport and abnormal tyrosinase routing in pink-eyed dilution melanocytes. , 1998, Experimental cell research.

[28]  P. Riley,et al.  Tyrosinase autoactivation and the problem of the lag period. , 1998, Pigment cell research.

[29]  I. Tannock,et al.  The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase. , 1998, British Journal of Cancer.

[30]  S. Simon,et al.  Defective Acidification in Human Breast Tumor Cells and Implications for Chemotherapy , 1998, The Journal of experimental medicine.

[31]  G. Hör,et al.  Primary staging and follow‐up of high risk melanoma patients with whole‐body 18F‐fluorodeoxyglucose positron emission tomography , 1998, Cancer.

[32]  S. Grinstein,et al.  Noninvasive measurement of the pH of the endoplasmic reticulum at rest and during calcium release. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Shabanowitz,et al.  The Class I Antigen-processing Pathway for the Membrane Protein Tyrosinase Involves Translation in the Endoplasmic Reticulum and Processing in the Cytosol , 1998, The Journal of experimental medicine.

[34]  MH Brilliant,et al.  Mutations of the human P gene associated with type II oculocutaneous albinism (OCA2) , 1998 .

[35]  F. Marincola,et al.  Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy. , 1998, Journal of immunotherapy.

[36]  J. Nordlund The pigmentary system : physiology and pathophysiology , 1998 .

[37]  D. Leeper,et al.  Altered proton extrusion in cells adapted to growth at low extracellular pH , 1997, Journal of cellular physiology.

[38]  C. A. Ramsden,et al.  Evidence of the Indirect Formation of the Catecholic Intermediate Substrate Responsible for the Autoactivation Kinetics of Tyrosinase* , 1997, The Journal of Biological Chemistry.

[39]  C. Dang,et al.  Oncogenes in Tumor Metabolism, Tumorigenesis, and Apoptosis , 1997, Journal of bioenergetics and biomembranes.

[40]  M. Finbow,et al.  The vacuolar H+-ATPase: a universal proton pump of eukaryotes. , 1997, The Biochemical journal.

[41]  R. Halaban,et al.  Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  T. Stevens,et al.  Structure, function and regulation of the vacuolar (H+)-ATPase. , 1997, Annual review of cell and developmental biology.

[43]  K. Altendorf,et al.  Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. , 1997, The Journal of experimental biology.

[44]  A Sette,et al.  Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes , 1996, The Journal of experimental medicine.

[45]  S. Simon,et al.  Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7adr). , 1996, Biochemistry.

[46]  H. Ploegh,et al.  Misfolded major histocompatibility complex class I molecules accumulate in an expanded ER-Golgi intermediate compartment , 1995, The Journal of cell biology.

[47]  D. Schadendorf,et al.  Membrane transport proteins associated with drug resistance expressed in human melanoma. , 1995, The American journal of pathology.

[48]  W. K. Schmidt,et al.  Ionic milieu controls the compartment-specific activation of pro-opiomelanocortin processing in AtT-20 cells. , 1995, Molecular biology of the cell.

[49]  Yao-Tseng Chen,et al.  Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Houghton,et al.  Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein, gp75 , 1995, The Journal of cell biology.

[51]  K. Sakaguchi,et al.  Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. , 1995, Journal of immunology.

[52]  D. Leeper,et al.  Extracellular pH distribution in human tumours. , 1995, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[53]  M. Brilliant,et al.  Identification of a melanosomal membrane protein encoded by the pink-eyed dilution (type II oculocutaneous albinism) gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[54]  W. Berger,et al.  Intrinsic MDR‐1 gene and P‐glycoprotein expression in human melanoma cell lines , 1994, International journal of cancer.

[55]  A. Helenius,et al.  Quality control in the secretory pathway: retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus , 1994, The Journal of cell biology.

[56]  R. Spritz,et al.  Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. , 1994, The New England journal of medicine.

[57]  S. Simon,et al.  Intracellular pH and the control of multidrug resistance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[58]  R. Gillies,et al.  Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. , 1993, The American journal of physiology.

[59]  I. Roninson,et al.  MDR-1 expression in metastatic malignant melanoma. , 1993, The Journal of surgical research.

[60]  R. Spritz,et al.  A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism , 1993, Nature.

[61]  M. Gerretsen,et al.  A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group. , 1990, British Journal of Cancer.

[62]  R. Gillies,et al.  A Plasma Membrane V‐type H+‐ATPase May Contribute to Elevated Intracellular pH (pHin) in Some Human Tumor Cells a , 1992, Annals of the New York Academy of Sciences.

[63]  M. Lyon,et al.  The Mouse Pink-Eyed Dilution Gene: Association with Human Prader-Willi and Angelman Syndromes , 1992, Science.

[64]  M. Brilliant,et al.  Direct molecular identification of the mouse pink-eyed unstable mutation by genome scanning. , 1991, Science.

[65]  P. Natali,et al.  Production and characterization of the murine monoclonal antibody 2G10 to a human T4-tyrosinase epitope. , 1991, The Journal of investigative dermatology.

[66]  R. Gillies,et al.  Tumorigenic 3T3 cells maintain an alkaline intracellular pH under physiological conditions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[67]  B. Kwon,et al.  Tyrosinases of murine melanocytes with mutations at the albino locus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[68]  I Mellman,et al.  Acidification of the endocytic and exocytic pathways. , 1986, Annual review of biochemistry.

[69]  James J. Nordlund,et al.  THE PIGMENTARY SYSTEM , 1985 .

[70]  E. Racker The Warburg effect: two years later. , 1983, Science.

[71]  A. Tartakoff Perturbation of vesicular traffic with the carboxylic ionophore monensin , 1983, Cell.

[72]  F. Maxfield Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts , 1982, The Journal of cell biology.

[73]  H. Lodish,et al.  Intracellular transport of secretory and membrane proteins in hepatoma cells infected by vesicular stomatitis virus , 1980, Cell.

[74]  A. Tartakoff,et al.  Plasma cell immunoglobulin secretion. Arrest is accompanied by alterations the golgi complex , 1977, The Journal of experimental medicine.

[75]  R. Halaban,et al.  Tyrosinase and inhibition of proliferation of melanoma cells and fibroblasts. , 1977, Experimental cell research.

[76]  S. Pomerantz A sensitive new assay for the oxidation of 3,4-dihydroxy L-phenylalanine by tyrosinase. , 1976, Analytical biochemistry.

[77]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.

[78]  T. Fitzpatrick,et al.  Mammalian tyrosinase; preparation and properties. , 1949, The Journal of biological chemistry.

[79]  H. Raper THE AEROBIC OXIDASES , 1928 .